Sanofi reports Q3 earnings beat; raises FY22 EPS guidance

Oct. 28, 2022 1:51 AM ETSanofi (SNY)By: Meghavi Singh, SA News Editor
  • Sanofi press release (NASDAQ:SNY): Q3 Non-GAAP EPS of €2.88 beats by €0.22.
  • Revenue of €12.48B (+19.7% Y/Y) beats by €440M, sales growth of 9.0% at CER driven by Specialty Care and Vaccines.
  • Specialty Care grew 19.9% driven by Dupixent® performance (€2,314M, +44.5%) and launch momentum in

Recommended For You


To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.
Is this happening to you frequently? Please report it on our feedback forum.
If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh.